Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure

S Singh, A Pandey, IJ Neeland - Progress in cardiovascular diseases, 2020 - Elsevier
Natriuretic peptides (NPs, B-type natriuretic peptide/BNP and NT-proBNP) are universally
used biomarkers with established cut-points to aid in the diagnosis of heart failure (HF). It …
被引用次数：22 相关文章

Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure

S Singh, A Pandey, IJ Neeland - Progress in …, 2020 - pubmed.ncbi.nlm.nih.gov
Natriuretic peptides (NPs, B-type natriuretic peptide/BNP and NT-proBNP) are universally
used biomarkers with established cut-points to aid in the diagnosis of heart failure (HF). It …
[HTML] nih.gov

[HTML][HTML] Diagnostic and Prognostic Considerations for Use of Natriuretic Peptides in Obese Patients with Heart Failure

S Singh, A Pandey, IJ Neeland - Progress in cardiovascular …, 2020 - ncbi.nlm.nih.gov
Natriuretic peptides (NPs, B-type natriuretic peptide/BNP and NT-proBNP) are universally
used biomarkers with established cut-points to aid in the diagnosis of heart failure (HF). It …

Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure.

S Singh, A Pandey, IJ Neeland - Progress in Cardiovascular …, 2020 - europepmc.org
Natriuretic peptides (NPs, B-type natriuretic peptide/BNP and NT-proBNP) are universally
used biomarkers with established cut-points to aid in the diagnosis of heart failure (HF). It …

Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure

S Singh, A Pandey, IJ Neeland - Progress in …, 2020 - utsouthwestern.elsevierpure.com
Natriuretic peptides (NPs, B-type natriuretic peptide/BNP and NT-proBNP) are universally
used biomarkers with established cut-points to aid in the diagnosis of heart failure (HF). It …